Stockscreener 앱 받기
0.71%
전일 마감가:
$1.76
열려 있는:
$1.84
하루 거래량:
8.79M
Relative Volume:
0.71
시가총액:
$1.18B
수익:
$29.48M
순이익/손실:
$-201.19M
주가수익비율:
-5.5469
EPS:
-0.32
순현금흐름:
$-216.50M
1주 성능:
-25.84%
1개월 성능:
-37.81%
6개월 성능:
-59.72%
1년 성능:
-21.57%
1일 변동 폭
$1.76
$1.9099
1주일 범위
$1.4601
$2.42
52주 변동 폭
$1.4601
$5.34
제론 Stock (GERN) Company Profile
명칭
Geron Corp
전화
(650) 473-7700
주소
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
GERN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.775 | 1.18B | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.63 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
688.49 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
634.75 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.35 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
112.69 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
제론 Stock (GERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-27 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | 개시 | H.C. Wainwright | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-09 | 개시 | Leerink Partners | Outperform |
| 2024-04-30 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | 개시 | TD Cowen | Buy |
| 2024-03-15 | 재확인 | Needham | Buy |
| 2023-09-12 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-03-28 | 개시 | Goldman | Neutral |
| 2022-10-28 | 개시 | Wedbush | Outperform |
| 2022-07-28 | 재개 | B. Riley Securities | Buy |
| 2021-11-02 | 개시 | Robert W. Baird | Outperform |
| 2021-02-18 | 재개 | B. Riley Securities | Buy |
| 2020-08-03 | 개시 | Stifel | Buy |
| 2019-11-19 | 재개 | B. Riley FBR | Buy |
| 2019-09-03 | 개시 | H.C. Wainwright | Buy |
| 2019-08-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-04-09 | 업그레이드 | Needham | Hold → Buy |
| 2019-01-31 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | 개시 | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | 재확인 | FBR & Co. | Outperform |
| 2016-09-13 | 재확인 | FBR Capital | Outperform |
| 2015-12-07 | 재확인 | Piper Jaffray | Overweight |
| 2015-04-21 | 개시 | Oppenheimer | Outperform |
| 2014-06-12 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-03-12 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2013-12-10 | 재확인 | MLV & Co | Buy |
| 2013-12-10 | 업그레이드 | Needham | Hold → Buy |
| 2013-11-08 | 재확인 | MLV & Co | Buy |
| 2013-10-16 | 개시 | MLV & Co | Buy |
| 2012-08-30 | 개시 | Stifel Nicolaus | Buy |
| 2012-06-28 | 개시 | Needham | Hold |
모두보기
제론 주식(GERN)의 최신 뉴스
Geron Corp’s chief commercial officer buys $160,000 in stock By Investing.com - Investing.com South Africa
Geron corp EVP Scott Samuels buys $24,150 in common stock By Investing.com - Investing.com Australia
Geron corp EVP Scott Samuels buys $24,150 in common stock - Investing.com India
Geron Corp’s chief commercial officer buys $160,000 in stock - Investing.com
Geron Corp Executives Make Significant Stock Purchases - TradingView
Geron (NASDAQ:GERN) Trading Up 9%Here's Why - MarketBeat
Geron (NASDAQ:GERN) Price Target Lowered to $4.00 at Stifel Nicolaus - MarketBeat
Geron (NASDAQ:GERN) Lowered to Neutral Rating by B. Riley - MarketBeat
Geron (GERN) to Release Earnings on Wednesday - MarketBeat
Geron (NASDAQ:GERN) Issues Earnings Results, Hits Estimates - MarketBeat
Geron (NASDAQ:GERN) Announces Quarterly Earnings Results - MarketBeat
Geron (NASDAQ:GERN) Cut to Neutral at HC Wainwright - MarketBeat
Stifel cuts Geron stock target to $4, maintains buy rating - Investing.com
Stifel cuts Geron stock target to $4, maintains buy rating By Investing.com - Investing.com South Africa
Geron price target lowered to $4 from $6 at Scotiabank - TipRanks
Scotiabank cuts Geron stock target to $4, keeps outperform rating - Investing.com India
Geron Corporation (NASDAQ:GERN) Q4 2024 Earnings Call Transcript - Insider Monkey
Scotiabank cuts Geron stock target to $4, keeps outperform rating By Investing.com - Investing.com South Africa
We Think Geron (NASDAQ:GERN) Can Afford To Drive Business Growth - Yahoo Finance
We're Hopeful That Geron (NASDAQ:GERN) Will Use Its Cash Wisely - Simply Wall St
GERON CORP SEC 10-K Report - TradingView
Geron Corporation Reports Strong 2024 Financial Results - TipRanks
Geron stock plunges 30% following Q4 report - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron CorporationGERN - PR Newswire
Geron (GERN) Stock Declines Amid Weak Rytelo Outlook - GuruFocus.com
Why Geron Stock Is Plummeting Today - MSN
Geron: Q4 Earnings Snapshot - mySA
Wedbush Lowers Geron's Price Target to $7 From $8, Outperform Rating Maintained - Marketscreener.com
Geron stock rating downgraded on flat revenue outlook By Investing.com - Investing.com South Africa
Geron Inc.: Strategic Market Position and Rytelo’s Potential Justify Buy Rating - TipRanks
TD Cowen cuts Geron stock price target to $5, maintains Buy rating - Investing.com
HC Wainwright Downgrades Geron to Neutral From Buy -February 26, 2025 at 12:35 pm EST - Marketscreener.com
Geron (GERN) Q4 2024 Earnings Call Transcript - Yahoo
Geron: Rytelo's Market Share Concerns Justified As 3L Dominates Early Sales (NASDAQ:GERN) - Seeking Alpha
Geron earnings missed by $0.01, revenue fell short of estimates - Investing.com India
Geron (NASDAQ:GERN) Hits New 1-Year LowTime to Sell? - MarketBeat
Geron stock plunges 30% amid Rytelo sales concerns (update) - MSN
Geron Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Geron Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
Geron reports Q4 EPS (4c), consensus (5c) - TipRanks
Geron stock tumbles on disappointing guidance By Investing.com - Investing.com Australia
Geron stock tumbles on disappointing guidance - Investing.com
Earnings call transcript: Geron Q4 2024 misses EPS, stock plummets - Investing.com
Geron stock touches 52-week low at $1.63 amid market fluctuations - Investing.com
Geron (GERN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Geron's Q4 Net Loss Narrows, Revenue Rises -February 26, 2025 at 07:59 am EST - Marketscreener.com
Geron: Q4 Earnings Snapshot -February 26, 2025 at 07:52 am EST - Marketscreener.com
Geron Corporation Q4 Loss Decreases, Beats Estimates - Nasdaq
Earnings Flash (GERN) GERON CORPORATION Posts Q4 Revenue $47.5M, vs. FactSet Est of $61.8M - Marketscreener.com
Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - The Bakersfield Californian
Can Geron's $47.5M RYTELO Revenue Transform This Cancer Treatment Company? - StockTitan
제론 (GERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
제론 주식 (GERN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SCARLETT JOHN A | Chairman, President and CEO |
Feb 27 '25 |
Buy |
1.76 |
12,500 |
22,062 |
12,500 |
| Ziegler James | EVP, Chief Commercial Officer |
Feb 27 '25 |
Buy |
1.60 |
100,000 |
160,000 |
100,000 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer |
Jul 08 '24 |
Option Exercise |
1.72 |
674,348 |
1,159,879 |
674,348 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer |
Jul 08 '24 |
Sale |
4.56 |
674,348 |
3,073,004 |
0 |
| Feller Faye | EVP, Chief Medical Officer |
Jun 10 '24 |
Option Exercise |
1.19 |
287,900 |
341,693 |
155,400 |
| Feller Faye | EVP, Chief Medical Officer |
Jun 10 '24 |
Sale |
4.63 |
287,900 |
1,334,129 |
0 |
| Kapur Anil | EVP, Corp Strategy & CCO |
Jun 10 '24 |
Option Exercise |
1.06 |
421,875 |
447,188 |
421,875 |
| Kapur Anil | EVP, Corp Strategy & CCO |
Jun 10 '24 |
Sale |
4.64 |
421,875 |
1,959,609 |
0 |
| SCARLETT JOHN A | Chairman, President and CEO |
Jun 04 '24 |
Option Exercise |
2.54 |
600,000 |
1,524,000 |
600,000 |
| SCARLETT JOHN A | Chairman, President and CEO |
Jun 04 '24 |
Sale |
4.00 |
600,000 |
2,400,000 |
600,000 |
3.91%
1.68%
자본화:
|
볼륨(24시간):